Getting Foxy with Doxy: Sexual Health Promotion and STI Prevention Update

Session Details

Description:

This Grand Rounds session will cover key updates in STI prevention, including HIV PrEP advancements, doxycycline for bacterial STI PEP, and current STI trends in New York. The session will convene subject-matter experts to equip New York healthcare professionals with the latest knowledge and tools to enhance their practice in preventing and managing human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs).

Presentation:

Moderator:

James V. McDonald, MD, MPH
Commissioner of the New York State Department of Health

Presenter(s):

Philip A. Chan, MD, MS, is an Associate Professor in the Department of Medicine and School of Public Health at Brown University and infectious diseases physician. Dr. Chan is Chief Medical Officer at Open Door Health, the state's only community-based LGBTQ+ clinic. Dr. Chan also serves as Consultant Medical Director for the Rhode Island Department of Health Division of Preparedness, Response, Infectious Disease and EMS (PRIDEMS). He is working with the Department of Health and other community organizations on several statewide initiatives related to HIV and other sexually transmitted infections (STI). Dr. Chan also served as a Medical Consultant in the Division of STD Prevention (DSTDP) at the Centers for Disease Control and Prevention (CDC) and assisted in writing the 2021 STI Treatment Guidelines and the 2024 DoxyPEP Guidelines.

Rachel Hart-Malloy, PhD, MPH has worked in the field of public health for almost 20 years, with a predominate focus on sexually transmitted infections and sexual health. She currently serves as the Director of the Office of Sexual Health and Epidemiology, at the New York State Health Department's AIDS Institute. In this role, she supports work towards individualizing and normalizing sexual health; ensuring the prevention, treatment, and elimination of sexually transmitted infections; and implementing a holistic community impact. Dr. Hart-Malloy additionally serves as an Assistant Professor at the University at Albany, School of Public Health, Department of Epidemiology and Biostatistics since 2012, and an associated faculty member with the Center for Collaborative HIV Research in Policy and Practice since 2018.

Special Guest(s):

Dr. Norton is an Infectious Diseases physician, and currently the Deputy Medical Director of the AIDS Institute at the NYS Department of Health. Previously, Dr. Norton spent the last decade at Albert Einstein College of Medicine in the Bronx, NY treating patients for HIV, Hepatitis C, and opioid use disorder in community settings such as primary care clinics, methadone treatment programs, and syringe exchange programs. Dr. Norton also opened one of the first drug user health clinics that was located onsite at a syringe exchange program in East Harlem.

Dr. Jason Zucker is an Assistant Professor of Medicine in Infectious Diseases at Columbia University Irving Medical Center and Assistant Medical Director of the NYC STD Prevention Training Center. Trained in both adult and pediatric infectious diseases, he provides status-neutral sexual health care to patients of all ages at NewYork-Presbyterian/Columbia's Sexual Health Clinic. His research intersects data science, behavioral science, and implementation science, focusing on optimizing engagement in the sexual health cascade of care. Dr. Zucker is a PI/co-PI on two NIH-funded studies: STIckER, a digital decision aid for STI testing, and Doxy4STICare, which addresses engagement and resistance in Doxy-PEP and is a vice-chair of the NIH funded study of tecovirimat for mpox (STOMP) trial. He has contributed to New York State's EPT question and answer guidance and the Congenital Syphilis Elimination Strategic Planning Group. Additionally, he serves as a CDC consultant for the upcoming STI Treatment Guidelines.

Dr Beil is an Associate Professor of Medicine at Albert Einstein College of medicine and a general internist int he Montefiore Medical Group where he has provided primary care in the South Bronx since 1993. He is the Medical Director of the CICERO Program which is the Montefiore Ryan White HIV Care program operating in 10 community Health Centers and also the Montefiore Prevention Program, which does outreach and provides sexual health to sexual and gender minority people in the Bronx. Additionally, he Is the Medical Director of the TransWellness Centers at Montefiore, which provides gender affirming care to TGD individuals in the Montefiore Health System. His research and educational work surround the care of sexual and gender minority populations in the Bronx and the effective delivery of HIV care in urban primary care settings.

Continuing Education Information:

To Obtain Continuing Education Credits:

Participants seeking CE credits must register with their email, attend the entire live session, and complete an evaluation and post-test available at the end of the session.

Accreditation Statement:

This activity is planned and implemented in accordance with the ACCME's Accreditation Requirements and Policies through the joint providership of the Medical Society of the State of New York (MSSNY) and The New York State Department of Health. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

MSSNY designates this Grand Rounds session for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with their participation.

Disclosure Statement:

As an ACCME-accredited provider, MSSNY is required to identify and mitigate relevant financial relationships of all individuals in control of CME content. Relevant financial relationships exist if:

  • A financial relationship, in any amount, exists between the content controller and an ineligible company.
  • The financial relationship existed in the past 24 months.
  • The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.

**John Maese, MD has disclosed that he owns stock in Eli Lilly, Johnson & Johnson, Danaher Corp, Takeda Pharmaceutical Co Ltd, and Bausch Health Companies Inc. The planners, moderator, presenters, and other individuals in control of content do not have any financial arrangements or affiliations with any ineligible companies whose products, research or services may be discussed in this activity. All relevant financial relationships have been mitigated.

**No commercial funding has been accepted for this activity.